GlassScriptPhysician profile
Federico C Vinas
NPI 1184601304
$63,838.72
in general payments reported to CMS, 2019-2025
39 companies · $579 in 2025
The $579 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $9,826 · 2021: $23K · 2022: $1,152 · 2023: $558 · 2024: $5,543 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Food and Beverage: $1,660 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Food and Beverage | $1,659.86 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Captiva Spine INC | $36,963.68 | 2019-2024 | Smartlox |
| Orthofix Medical, INC. | $23,489.49 | 2019-2023 | Spinal-Stim, Cervical-Stim |
| Integra Lifesciences Corporation | $525.95 | 2019-2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Depuy Synthes Sales INC. | $336.37 | 2019-2024 | Na, Viper |
| Stryker Corporation | $258.77 | 2021-2025 | Spinejack |
| Surgalign Spine Technologies, INC. | $226.33 | 2021 | |
| Si-Bone, INC. | $197.80 | 2019-2023 | |
| Medtronic, INC. | $176.79 | 2022-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Astrazeneca Pharmaceuticals LP | $145.12 | 2022-2023 | Andexxa |
| Ethicon US, LLC | $142.11 | 2022-2023 | Vistaseal, Surgiflo Hemostatic Matrix, Ethicon |
| Lemaitre Vascular, INC. | $122.82 | 2022-2024 | Anastoclip Gc 8cm (Medium) |
| Zimmer Biomet Holdings, INC. | $121.77 | 2020-2023 | Thinflap |
| Nico Corporation | $115.14 | 2024 | |
| Novocure INC. | $103.63 | 2024 | Optune |
| Nevro Corp. | $81.93 | 2022-2024 | Senza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragen, INC. | $80.57 | 2023-2025 | Actastim-S |
| Ebi, LLC | $59.64 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Medtronic USA, INC. | $53.64 | 2019 | |
| Microtransponder, INC. | $53.14 | 2025 | |
| Icotec Medical INC. | $52.50 | 2022 | |
| Baxter Healthcare | $51.07 | 2022-2023 | Floseal |
| Intrinsic Therapeutics | $50.54 | 2020 | |
| Highridge Medical LLC | $35.23 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Spine Wave, INC. | $35.12 | 2021 | |
| Heron Therapeutics, INC. | $35.09 | 2023-2024 | Zynrelef |
| Reel Surgical, INC. | $32.77 | 2025 | |
| Zimvie INC. | $30.91 | 2022 | |
| Portola Pharmaceuticals, LLC | $30.26 | 2019-2020 | |
| Abbvie INC. | $28.42 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.40 | 2025 | |
| Ossdsign USA Incorporated | $24.24 | 2025 | Ossdsign Catalyst |
| Servier Pharmaceuticals LLC | $24.24 | 2024 | |
| Boston Scientific Corporation | $22.52 | 2025 | General - Pain Management |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Davol INC. | $19.84 | 2025 | Avitene Ultrafoam |
| Bioventus LLC | $17.77 | 2020 | |
| Relievant Medsystems, INC. | $16.98 | 2021 | |
| Innovation Technologies INC | $16.30 | 2025 | Irrisept |
| Arteriocyte Medical Systems, INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Federico Vinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.